Gene · 246100
Papers4,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanism of action of over-expressing NY-ESO-1 in vesicular stomatitis virus and its combination therapy with NY-ESO-1 TCR-T. | Front Immunol | 2025 | 40873562 | PubTator, text mining | PubMed |
| The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping. | Viruses | 2025 | 40872751 | PubTator, text mining | PubMed |
| An indirect ELISA for the detection of anti-NY-ESO-1 antibodies in cancer patients and for monitoring cancer therapy. | Mol Immunol | 2025 | 40865252 | PubTator, text mining | PubMed |
| Immunologic Alteration After Total En-Bloc Spondylectomy with Anterior Spinal Column Reconstruction with Frozen Tumor-Containing Bone Autologous Grafts: A Case Report in a Prospective Study. | Curr Oncol | 2025 | 40862801 | PubTator, text mining | PubMed |
| The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis. | J Cancer Res Clin Oncol | 2025 | 40844552 | PubTator, text mining | PubMed |
| Leveraging Immunological Properties of Nucleic Acid Nanoparticles to Improve Cancer Therapy. | RNA Nanomed | 2025 | 40831543 | PubTator, text mining | PubMed |
| Analysis of prostatic spindle cell lesions: Three case reports and literature review. | Medicine (Baltimore) | 2025 | 40826697 | PubTator, text mining | PubMed |
| Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidates. | NPJ Vaccines | 2025 | 40819132 | PubTator, text mining | PubMed |
| Adoptive T-Cell Therapy in Sarcomas. | Curr Oncol Rep | 2025 | 40810970 | PubTator, text mining | PubMed |
| Checkpoint immunotherapy is associated with preferential activation of tumor antigen-specific CD4+ T cells in MDS. | Blood Neoplasia | 2025 | 40809194 | PubTator, text mining | PubMed |
| Benign-malignant breast nodule discrimination model based on age, tumor-associated autoantibody, ultrasonography and mammography. | Int J Biol Markers | 2025 | 40785296 | PubTator, text mining | PubMed |
| Therapeutic anti-cancer vaccines: a systematic review of prospective intervention trials for common hematological malignancies. | EClinicalMedicine | 2025 | 40735344 | PubTator, text mining | PubMed |
| De novo design and structure of a peptide-centric TCR mimic binding module. | Science | 2025 | 40705894 | PubTator, text mining | PubMed |
| De novo-designed pMHC binders facilitate T cell-mediated cytotoxicity toward cancer cells. | Science | 2025 | 40705893 | PubTator, text mining | PubMed |
| Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation. | Mol Ther Nucleic Acids | 2025 | 40673161 | PubTator, text mining | PubMed |
| Current Anti-Myeloma Chimeric Antigen Receptor-T Cells: Novel Targets and Methods. | Balkan Med J | 2025 | 40619794 | PubTator, text mining | PubMed |
| [Perinephric myxoid pseudotumor of fat: a clinicopathological study of five cases]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 40619261 | PubTator, text mining | PubMed |
| Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study. | Ann Gastroenterol Surg | 2025 | 40607289 | PubTator, text mining | PubMed |
| Human cDC1 enhance cytotoxic function of CD226+ terminally exhausted tumor-infiltrating lymphocytes. | Oncoimmunology | 2025 | 40548437 | PubTator, text mining | PubMed |
| Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges. | World J Transplant | 2025 | 40535484 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/246100/papers?page=5